152 related articles for article (PubMed ID: 24452366)
1. Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.
Del Principe MI; Cefalo M; Buccisano F; Anemona L; Sarlo C; Di Caprio L; De Santis G; Giacobbi E; Maurillo L; Postorino M; Del Poeta G; Amadori S; Venditti A
Ann Hematol; 2014 Sep; 93(9):1611-2. PubMed ID: 24452366
[No Abstract] [Full Text] [Related]
2. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
Zhu K; Chen J; Chen S
Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune cytopenias in chronic lymphocytic leukemia.
D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening complication of Rituximab in a child.
Bader-Meunier B; Gabolde M; Casadevall N; Seguin G; Tchernia G
Haematologica; 2002 Dec; 87(12):ECR45. PubMed ID: 12553334
[No Abstract] [Full Text] [Related]
5. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation.
Jericho H; Weinstein J; Melin-Aldana H; Leuer KC; Wyers M; Alonso EM; Ekong UD
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):e2-4. PubMed ID: 24378523
[No Abstract] [Full Text] [Related]
7. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder of plasma cell type following allogeneic haemopoietic stem cell transplant treated with rituximab.
Getta B; Kwan J
Intern Med J; 2014 Aug; 44(8):821. PubMed ID: 25081050
[No Abstract] [Full Text] [Related]
9. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.
Zecca M; De Stefano P; Nobili B; Locatelli F
Blood; 2001 Jun; 97(12):3995-7. PubMed ID: 11389047
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
[TBL] [Abstract][Full Text] [Related]
11. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
Bond J; Shahdadpuri R; Mc Mahon C; O'marcaigh A; Cotter M; Smith O
Pediatr Blood Cancer; 2007 Oct; 49(5):761-2. PubMed ID: 17066466
[No Abstract] [Full Text] [Related]
13. Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.
D'Arena G; Vigliotti ML; Dell'Olio M; Villa MR; Mantuano S; Scalzulli PR; La Sala A; Abbadessa A; Mastrullo L; Cascavilla N
Eur J Haematol; 2009 Mar; 82(3):235-9. PubMed ID: 19067738
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
[No Abstract] [Full Text] [Related]
15. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
[TBL] [Abstract][Full Text] [Related]
16. [Follicular lymphoma complicated with autoimmune hemolytic anemia and pure red cell aplasia].
Nakashima Y; Abe Y; Ohtsuka R; Tachikawa Y; Nagasawa E; Nishimura J; Ohshima K; Nawata H; Muta K
Rinsho Ketsueki; 2004 Nov; 45(11):1208-10. PubMed ID: 15609689
[TBL] [Abstract][Full Text] [Related]
17. Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
Krečak I; Čengić M; Skorić I; Nakić M; Gverić-Krečak V
Ann Hematol; 2021 Nov; 100(11):2861-2862. PubMed ID: 34109444
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia.
Katayama H; Takeuchi M; Yoshino T; Munemasa M; Tada A; Soda R; Takahashi K
Leuk Lymphoma; 2001 Jul; 42(3):539-42. PubMed ID: 11699422
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
Cooles FA; Jackson GH; Menon G; Isaacs JD
Rheumatology (Oxford); 2011 Apr; 50(4):810-2. PubMed ID: 21208978
[No Abstract] [Full Text] [Related]
20. Pure red cell aplasia associated with non-Hodgkin's lymphoma and hemolytic anemia.
Suzuki A; Takahashi T; Taniguchi A; Kotake C; Seo T; Toda T; Kobayashi K; Tsukamoto N; Fukumoto M
Jpn J Clin Oncol; 1991 Oct; 21(5):384-7. PubMed ID: 1753420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]